About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3630266
Allelic
Composition
Irf2tm1Mak/Irf2tm1Mak
Genetic
Background
involves: 129S2/SvPas * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Irf2tm1Mak mutation (1 available); any Irf2 mutation (24 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• activated/memory CD8+ T cells become more prominent in the spleen after 3 months and after 5 months their percentage exceeds 80%
• inguinal lymph nodes have 3 times the number of cells as do wild-type and heterozygous littermates as the disease progresses
• as skin diseases advances, draining lymph nodes become enlarged
• signs of progressive cutaneous inflammation begin as early as 8 weeks of age

hematopoietic system
• activated/memory CD8+ T cells become more prominent in the spleen after 3 months and after 5 months their percentage exceeds 80%

integument
• signs of progressive cutaneous inflammation begin as early as 8 weeks of age
• hair loss begins as early as 8 weeks of age and eventually extends over the entire trunk
• thickening of the epidermis results from proliferation of keratinocytes in the basal epidermis
• homozygotes develop erythema as early as 8 weeks of age
• skin lesions occur, and excoriation of lesions results in ulcer formation eventually
• below the epidermis disorganization of the muscle layer and associated prominent fibrosis is seen


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
01/06/2026
MGI 6.24
The Jackson Laboratory